Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2003 | 06-2002 | 06-2001 | 06-2000 | 06-1999 | |
| Sales | 179,309 | 170,202 | 156,400 | 145,487 | 130,762 |
| Cost of Goods | 156,319 | 149,664 | 137,208 | 128,550 | 116,265 |
| Gross Profit | 22,990 | 20,538 | 19,192 | 16,937 | 14,497 |
| Operating Expenses | 14,928 | 11,808 | 11,036 | 9,449 | 8,530 |
| Operating Income | 8,062 | 8,730 | 8,156 | 7,488 | 5,967 |
| Interest Expense | 1,478 | 1,186 | 2,386 | 5,419 | 5,382 |
| Other Income | -899 | -236 | -998 | 19 | -168 |
| Pre-tax Income | 5,685 | 7,308 | 4,772 | 2,088 | 417 |
| Income Tax | 1,852 | 2,250 | 1,738 | 652 | 246 |
| Net Income Continuous | 3,833 | 5,058 | 3,034 | 1,436 | 171 |
| Net Income | $3,833 | $5,058 | $3,034 | $1,436 | $171 |
| EPS Basic Total Ops | 0.07 | 0.09 | 0.06 | 0.03 | 0.00 |
| EPS Basic Continuous Ops | 0.07 | 0.09 | 0.06 | 0.03 | 0.00 |
| EPS Diluted Total Ops | 0.07 | 0.09 | 0.06 | 0.03 | 0.00 |
| EPS Diluted Continuous Ops | 0.07 | 0.09 | 0.06 | 0.03 | 0.00 |
| EBITDA(a) | $8,411 | $9,783 | $8,343 | $8,453 | $6,655 |